Vol.

No.

November 04, 2022Nov 04, 2022

DOWNLOAD THE PDF

Pavan Reddy tells us how his research dovetails with running Baylor’s Dan L Duncan cancer center

Cover Story

Conversation with The Cancer Letter

Pavan Reddy tells us how his research dovetails with running Baylor’s Dan L Duncan cancer center

By Paul Goldberg

Pavan Reddy’s motivations to apply for the director’s job at Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center included his own research interests.

Regulatory News

ODAC considers the first application based wholly on RWE methodology—and nixes it unanimously

By Paul Goldberg

Conversation with The Cancer Letter

Children’s National and UCL team receives $25M Grand Challenges award to study CAR T in pediatric solid tumors

By Jacquelyn Cobb

Free In the Archives

Tobacco Awareness Month: Smoking in pharmaceutical advertising

In Brief

Robert Uzzo appointed president and CEO of Fox Chase

Jarett Rieger named vice president and chief innovation officer at Moffitt

Antonio Iavarone named deputy director at Sylvester

Jeannie Shen named medical director of the Breast Program and the International Health Program at the Cedars-Sinai affiliate

Cancer Grand Challenges launches global consultation to find cancer’s toughest challenges

Roy S. Herbst receives SWOG appreciation award

Brad Diephuis named chief business officer at Thyme Care

MD Anderson’s Pisters wins Astros v. Yankees bet with MSK’s Vickers

Clinical Roundup

UC study examines immunotherapy’s effect on COVID-19 outcomes

Mechanism identified for drug resistance in glioblastoma

ACS study shows cancer survivors at higher risk for bone fractures

Hopkins study shows extracellular viscosity linked to cancer spread

UCSD and VA San Diego study shows genetic score predicts risk of prostate cancer

Massey scientists find strong evidence for liver cancer drug

Hormone therapy could lower risk of immunotherapy-associated myocarditis in women

Drugs & Targets

FDA issues draft guidance on expanded access to investigational drugs

Veeva and Merck form long-term strategic partnership

Carrum Health and AccessHope partner to increase access to cost-effective cancer expertise

NCI Trials

NCI Trials for November 2022

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 42 - November 08, 2024